Skip to content
1887

Journal of General Virology header logo Journal of General Virology

Volume 107, Issue 3

The anti-viral protein Shiftless blocks p-body formation during KSHV infection Open Access

Abstract

Processing bodies (P-bodies/PBs) are non-membranous foci involved in coordinating RNA fate by regulating translation and mRNA decay. In this study, we characterize the anti-viral factor Shiftless (SHFL) as a potent disruptor of PB dynamics. We show SHFL expression restricts PB accumulation even in the context of oxidative stress, suggesting that SHFL expression impedes PB formation. Mutational approaches revealed that SHFL RNA-binding activity is not required to restrict PB formation. However, we have identified a new region of SHFL, a bridge between two distant SHFL domains, as necessary for SHFL-mediated PB disruption. Furthermore, we show that SHFL’s ability to disrupt PB formation also impacts its anti-viral activity during infection by the gammaherpesvirus Kaposi’s sarcoma-associated herpesvirus (KSHV). While WT SHFL efficiently restricts KSHV lytic reactivation, SHFL mutants defective in PB disruption no longer restrict KSHV reactivation. SHFL-mediated PB disruption also leads to increased expression of several anti-viral cytokines, further emphasizing the connection among SHFL, PB dynamics and the SHFL-dependent anti-viral state. Taken together, our observations suggest a role of SHFL in inhibiting PB formation to restrict KSHV lytic replication, reinforcing the importance of crosstalk between RNA fate and the innate immune response to viral infection.

  • Received:
  • Accepted:
  • Published Online:
Keyword(s): herpesvirus , Kaposi’s sarcoma-associated herpesvirus (KSHV) , processing body (P-body) , RNA decay and Shiftless (SHFL)
Funding
This study was supported by the:
  • NIH (Award R35GM138043)
    • Principal Award Recipient: MandyMuller
  • SNSF (Award 10005897)
    • Principal Award Recipient: MandyMuller
© 2026 The Authors
  • This is an open-access article distributed under the terms of the Creative Commons Attribution License.
Loading

Article metrics loading...

/content/journal/jgv/10.1099/jgv.0.002229
2026-03-13
2026-04-11

Metrics

Loading full text...

Full text loading...

/deliver/fulltext/jgv/107/3/jgv002229.html?itemId=/content/journal/jgv/10.1099/jgv.0.002229&mimeType=html&fmt=ahah

References

  1. Gilbertson S, Federspiel JD, Hartenian E, Cristea IM, Glaunsinger B. Changes in mRNA abundance drive shuttling of RNA binding proteins, linking cytoplasmic RNA degradation to transcription. Elife 2018; 7:e37663 [View Article] [PubMed]
     [Google Scholar]
  2. Hartenian E, Gilbertson S, Federspiel JD, Cristea IM, Glaunsinger BA. RNA decay during gammaherpesvirus infection reduces RNA polymerase II occupancy of host promoters but spares viral promoters. PLoS Pathog 2020; 16:e1008269 [View Article] [PubMed]
     [Google Scholar]
  3. Hartenian E, Glaunsinger BA. Feedback to the central dogma: cytoplasmic mRNA decay and transcription are interdependent processes. Crit Rev Biochem Mol Biol 2019; 54:385–398 [View Article] [PubMed]
     [Google Scholar]
  4. Lee YJ, Glaunsinger BA. Aberrant herpesvirus-induced polyadenylation correlates with cellular messenger RNA destruction. PLoS Biol 2009; 7:e1000107 [View Article] [PubMed]
     [Google Scholar]
  5. Abernathy E, Glaunsinger B. Emerging roles for RNA degradation in viral replication and antiviral defense. Virology 2015; 479–480:600–608 [View Article] [PubMed]
     [Google Scholar]
  6. Gaucherand L, Gaglia MM. The role of viral RNA degrading factors in shutoff of host gene expression. Annu Rev Virol 2022; 9:213–238 [View Article] [PubMed]
     [Google Scholar]
  7. Glaunsinger B, Ganem D. Highly selective escape from KSHV-mediated host mRNA shutoff and its implications for viral pathogenesis. J Exp Med 2004; 200:391–398 [View Article] [PubMed]
     [Google Scholar]
  8. Glaunsinger BA, Ganem DE. Messenger RNA turnover and its regulation in herpesviral infection. Adv Virus Res 2006; 66:337–394 [View Article] [PubMed]
     [Google Scholar]
  9. Muller M, Glaunsinger BA. Nuclease escape elements protect messenger RNA against cleavage by multiple viral endonucleases. PLoS Pathog 2017; 13:e1006593 [View Article] [PubMed]
     [Google Scholar]
  10. Muller M, Hutin S, Marigold O, Li KH, Burlingame A et al. A ribonucleoprotein complex protects the interleukin-6 mRNA from degradation by distinct herpesviral endonucleases. PLoS Pathog 2015; 11:e1004899 [View Article] [PubMed]
     [Google Scholar]
  11. Deng H, Chu JT, Rettig MB, Martinez-Maza O, Sun R. Rta of the human herpesvirus 8/Kaposi sarcoma-associated herpesvirus up-regulates human interleukin-6 gene expression. Blood 2002; 100:1919–1921 [View Article] [PubMed]
     [Google Scholar]
  12. McCormick C, Ganem D. The kaposin B protein of KSHV activates the p38/MK2 pathway and stabilizes cytokine mRNAs. Science 2005; 307:739–741 [View Article] [PubMed]
     [Google Scholar]
  13. Miles SA, Rezai AR, Salazar-González JF, Vander Meyden M, Stevens RH et al. AIDS Kaposi sarcoma-derived cells produce and respond to interleukin 6. Proc Natl Acad Sci USA 1990; 87:4068–4072 [View Article] [PubMed]
     [Google Scholar]
  14. Screpanti I, Musiani P, Bellavia D, Cappelletti M, Aiello FB et al. Inactivation of the IL-6 gene prevents development of multicentric Castleman’s disease in C/EBP beta-deficient mice. J Exp Med 1996; 184:1561–1566 [View Article] [PubMed]
     [Google Scholar]
  15. Sin SH, Roy D, Wang L, Staudt MR, Fakhari FD et al. Rapamycin is efficacious against primary effusion lymphoma (PEL) cell lines in vivo by inhibiting autocrine signaling. Blood 2007; 109:2165–2173 [View Article] [PubMed]
     [Google Scholar]
  16. Rodriguez W, Mehrmann T, Hatfield D, Muller M. Shiftless restricts viral gene expression and influences RNA granule formation during Kaposi’s sarcoma-associated herpesvirus lytic replication. J Virol 2022; 96:e0146922 [View Article] [PubMed]
     [Google Scholar]
  17. Rodriguez W, Srivastav K, Muller M. C19ORF66 broadly escapes virus-induced endonuclease cleavage and restricts Kaposi’s sarcoma-associated herpesvirus. J Virol 2019; 93:e00373-19 [View Article] [PubMed]
     [Google Scholar]
  18. Rodriguez W, Muller M. Shiftless, a critical piece of the innate immune response to viral infection. Viruses 2022; 14:1338 [View Article] [PubMed]
     [Google Scholar]
  19. Kinast V, Plociennikowska A, Bracht T, Todt D, Brown RJP et al. C19orf66 is an interferon-induced inhibitor of HCV replication that restricts formation of the viral replication organelle. J Hepatol 2020; 73:549–558 [View Article] [PubMed]
     [Google Scholar]
  20. Suzuki Y, Chin W-X, Han Q, Ichiyama K, Lee CH et al. Characterization of RyDEN (C19orf66) as an interferon-stimulated cellular inhibitor against dengue virus replication. PLoS Pathog 2016; 12:e1005357 [View Article] [PubMed]
     [Google Scholar]
  21. Wang X, Xuan Y, Han Y, Ding X, Ye K et al. Regulation of HIV-1 Gag-Pol expression by shiftless, an inhibitor of programmed -1 ribosomal frameshifting. Cell 2019; 176:625–635 [View Article] [PubMed]
     [Google Scholar]
  22. Wu Y, Yang X, Yao Z, Dong X, Zhang D et al. C19orf66 interrupts Zika virus replication by inducing lysosomal degradation of viral NS3. PLoS Negl Trop Dis 2020; 14:e0008083 [View Article]
     [Google Scholar]
  23. Yu D, Zhao Y, Pan J, Yang X, Liang Z et al. C19orf66 inhibits Japanese encephalitis virus replication by targeting -1 PRF and the NS3 protein. Virol Sin 2021; 36:1443–1455 [View Article] [PubMed]
     [Google Scholar]
  24. Riggs CL, Kedersha N, Ivanov P, Anderson P. Mammalian stress granules and P bodies at a glance. J Cell Sci 2020; 133:jcs242487 [View Article] [PubMed]
     [Google Scholar]
  25. Aizer A, Kalo A, Kafri P, Shraga A, Ben-Yishay R et al. Quantifying mRNA targeting to P-bodies in living human cells reveals their dual role in mRNA decay and storage. J Cell Sci 2014; 127:4443–4456 [View Article] [PubMed]
     [Google Scholar]
  26. Anderson P, Kedersha N. RNA granules. J Cell Biol 2006; 172:803–808 [View Article] [PubMed]
     [Google Scholar]
  27. Anderson P, Kedersha N. RNA granules: post-transcriptional and epigenetic modulators of gene expression. Nat Rev Mol Cell Biol 2009; 10:430–436 [View Article] [PubMed]
     [Google Scholar]
  28. Brengues M, Teixeira D, Parker R. Movement of eukaryotic mRNAs between polysomes and cytoplasmic processing bodies. Science 2005; 310:486–489 [View Article] [PubMed]
     [Google Scholar]
  29. Hubstenberger A, Courel M, Bénard M, Souquere S, Ernoult-Lange M et al. P-body purification reveals the condensation of repressed mRNA regulons. Mol Cell 2017; 68:144–157 [View Article] [PubMed]
     [Google Scholar]
  30. Wilbertz JH, Voigt F, Horvathova I, Roth G, Zhan Y et al. Single-molecule imaging of mRNA localization and regulation during the integrated stress response. Mol Cell 2019; 73:946–958 [View Article] [PubMed]
     [Google Scholar]
  31. Decker CJ, Parker R. P-bodies and stress granules: possible roles in the control of translation and mRNA degradation. Cold Spring Harb Perspect Biol 2012; 4:a012286 [View Article] [PubMed]
     [Google Scholar]
  32. Franks TM, Lykke-Andersen J. The control of mRNA decapping and P-body formation. Mol Cell 2008; 32:605–615 [View Article] [PubMed]
     [Google Scholar]
  33. Luo Y, Na Z, Slavoff SA. P-bodies: composition, properties, and functions. Biochemistry 2018; 57:2424–2431 [View Article] [PubMed]
     [Google Scholar]
  34. Parker R, Sheth U. P bodies and the control of mRNA translation and degradation. Mol Cell 2007; 25:635–646 [View Article] [PubMed]
     [Google Scholar]
  35. Standart N, Weil D. P-bodies: cytosolic droplets for coordinated mRNA storage. Trends Genet 2018; 34:612–626 [View Article] [PubMed]
     [Google Scholar]
  36. More N, Joseph J. Disruption of ER–mitochondria contact sites induces autophagy-dependent loss of P-bodies through the Ca2+-CaMKK2-AMPK pathway. J Cell Sci 2025; 138: [View Article]
     [Google Scholar]
  37. Roy R, Das G, Kuttanda IA, Bhatter N, Rajyaguru PI. Low complexity RGG-motif sequence is required for Processing body (P-body) disassembly. Nat Commun 2022; 13:2077 [View Article]
     [Google Scholar]
  38. Melemedjian OK, Mejia GL, Lepow TS, Zoph OK, Price TJ. Bidirectional regulation of P body formation mediated by eIF4F complex formation in sensory neurons. Neurosci Lett 2014; 563:169–174 [View Article] [PubMed]
     [Google Scholar]
  39. Palanisamy V, Jakymiw A, Van Tubergen EA, D’Silva NJ, Kirkwood KL. Control of cytokine mRNA expression by RNA-binding proteins and microRNAs. J Dent Res 2012; 91:651–658 [View Article]
     [Google Scholar]
  40. Wu X, Tommasi di Vignano A, Zhou Q, Michel-Dziunycz PJ, Bai F et al. The ARE-binding protein Tristetraprolin (TTP) is a novel target and mediator of calcineurin tumor suppressing function in the skin. PLoS Genet 2018; 14:e1007366 [View Article]
     [Google Scholar]
  41. Corcoran JA, McCormick C. Viral activation of stress-regulated Rho-GTPase signaling pathway disrupts sites of mRNA degradation to influence cellular gene expression. Small GTPases 2015; 6:178–185 [View Article] [PubMed]
     [Google Scholar]
  42. Franks TM, Lykke-Andersen J. TTP and BRF proteins nucleate processing body formation to silence mRNAs with AU-rich elements. Genes Dev 2007; 21:719–735 [View Article] [PubMed]
     [Google Scholar]
  43. Lin WJ, Duffy A, Chen CY. Localization of AU-rich element-containing mRNA in cytoplasmic granules containing exosome subunits. J Biol Chem 2007; 282:19958–19968 [View Article] [PubMed]
     [Google Scholar]
  44. Kleer M, Mulloy RP, Robinson C-A, Evseev D, Bui-Marinos MP et al. Human coronaviruses disassemble processing bodies. PLoS Pathog 2022; 18:e1010724 [View Article] [PubMed]
     [Google Scholar]
  45. D’Lima NG, Ma J, Winkler L, Chu Q, Loh KH et al. A human microprotein that interacts with the mRNA decapping complex. Nat Chem Biol 2017; 13:174–180 [View Article] [PubMed]
     [Google Scholar]
  46. Dougherty JD, White JP, Lloyd RE. Poliovirus-mediated disruption of cytoplasmic processing bodies. J Virol 2011; 85:64–75 [View Article] [PubMed]
     [Google Scholar]
  47. Pérez-Vilaró G, Fernández-Carrillo C, Mensa L, Miquel R, Sanjuan X et al. Hepatitis C virus infection inhibits P-body granule formation in human livers. J Hepatol 2015; 62:785–790 [View Article] [PubMed]
     [Google Scholar]
  48. Sharma NR, Majerciak V, Kruhlak MJ, Yu L, Kang JG et al. KSHV RNA-binding protein ORF57 inhibits P-body formation to promote viral multiplication by interaction with Ago2 and GW182. Nucleic Acids Res 2019; 47:9368–9385 [View Article] [PubMed]
     [Google Scholar]
  49. Bernstam L, Nriagu J. Molecular aspects of arsenic stress. J Toxicol Environ Health B Crit Rev 2000; 3:293–322 [View Article] [PubMed]
     [Google Scholar]
  50. Napthine S, Hill CH, Nugent HCM, Brierley I. Modulation of viral programmed ribosomal frameshifting and stop codon readthrough by the host restriction factor shiftless. Viruses 2021; 13:1230 [View Article] [PubMed]
     [Google Scholar]
  51. Abramson J, Adler J, Dunger J, Evans R, Green T et al. Accurate structure prediction of biomolecular interactions with AlphaFold 3. Nature 2024; 630:493–500 [View Article] [PubMed]
     [Google Scholar]
  52. Blake LA, Watkins L, Liu Y, Inoue T, Wu B. A rapid inducible RNA decay system reveals fast mRNA decay in P-bodies. Nat Commun 2024; 15:2720 [View Article] [PubMed]
     [Google Scholar]
  53. Reineke LC, Lloyd RE. Diversion of stress granules and P-bodies during viral infection. Virology 2013; 436:255–267 [View Article] [PubMed]
     [Google Scholar]
  54. Corcoran JA, Khaperskyy DA, Johnston BP, King CA, Cyr DP et al. Kaposi’s sarcoma-associated herpesvirus G-protein-coupled receptor prevents AU-rich-element-mediated mRNA decay. J Virol 2012; 86:8859–8871 [View Article] [PubMed]
     [Google Scholar]
  55. Robinson CA, Singh GK, Kleer M, Katsademas T, Castle EL et al. Kaposi’s sarcoma-associated herpesvirus (KSHV) utilizes the NDP52/CALCOCO2 selective autophagy receptor to disassemble processing bodies. PLoS Pathog 2023; 19:e1011080 [View Article] [PubMed]
     [Google Scholar]
  56. Tan C, Qin X, Tan Y, Dong X, Chen D et al. SHFL inhibits enterovirus A71 infection by triggering degradation of viral 3Dpol protein via the ubiquitin-proteasome pathway. J Med Virol 2023; 95:e29030 [View Article] [PubMed]
     [Google Scholar]
  57. Tang S, Zheng ZM. Kaposi’s sarcoma-associated herpesvirus K8 exon 3 contains three 5’-splice sites and harbors a K8.1 transcription start site. J Biol Chem 2002; 277:14547–14556 [View Article] [PubMed]
     [Google Scholar]
  58. Luna RE, Zhou F, Baghian A, Chouljenko V, Forghani B et al. Kaposi’s sarcoma-associated herpesvirus glycoprotein K8.1 is dispensable for virus entry. J Virol 2004; 78:6389–6398 [View Article] [PubMed]
     [Google Scholar]
  59. Raab MS, Albrecht JC, Birkmann A, Yağuboğlu S, Lang D et al. The immunogenic glycoprotein gp35-37 of human herpesvirus 8 is encoded by open reading frame K8.1. J Virol 1998; 72:6725–6731 [View Article] [PubMed]
     [Google Scholar]
/content/journal/jgv/10.1099/jgv.0.002229
Loading
The anti-viral protein Shiftless blocks p-body formation during KSHV infection
J. Gen. Virol. 107, 002229 (2026); https://doi.org/10.1099/jgv.0.002229
/content/journal/jgv/10.1099/jgv.0.002229
/content/journal/jgv/10.1099/jgv.0.002229
Loading

Data & Media loading...

Supplements

Supplementary material 1

PDF

Most cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An error occurred
Approval was partially successful, following selected items could not be processed due to error